UN had its first-ever peer review of medical cannabis

Last week, the UN had its first-ever peer review of medical cannabis.

In its review, the UN agency, the World Health Organization (WHO), reported that medical cannabis is a relatively safe drug that can be used as a treatment for a wide range of medical conditions.

The WHO report comprised of 953 medical marijuana patients from 31 different countries. It is estimated that approximately 2.2 million people already use medical marijuana in the United States.

Read the full report HERE.

Most of them were prescribed or recommended to use the drug from doctors.

Some of the common uses of medical marijuana are chronic pain, sleep disturbances, epilepsy, and anxiety.

An analysis of different studies was also in the report.

One of the studies showed that there were a greater number of people, who use marijuana medically to those who use it for recreational purposes

However, another two studies showed there is little to no difference in people who use marijuana for recreational or medical purposes.

Studies show that medical marijuana helps with pain, sleep disturbances, and anxiety (Image via Leafly)

Development in medical marijuana

People who suffer from Parkinson disease have reported that marijuana has helped with their mobile skills.

In addition, clinical trials have shown that vaped marijuana is a treatment for neuropathic pain and pain associated with diabetic peripheral neuropathy.

An increase in appetite and weight gain has been found in HIV/AIDS patients.

Cannabis oil has been found to be a good treatment for people suffering from dementia, motor neuron disease, and neurogenic issues.

Reports also show that marijuana could help to reduce opioid use and addiction.

The FDA has approved two cannabinoids, dronabinol and nabilone in the U.S to reduce the side effects caused by chemotherapy.